Research news

A new scan could improve how millions of people with high blood pressure are treated, suggests a new study led by UCL and conducted at UCLH.

Patients with an aggressive form of leukaemia will now be able to receive a breakthrough immunotherapy on the NHS which was developed and trialled at UCLH and UCL.

The Queen Square Clinical Trial Centre (QSCTC) has successfully delivered its first investigational medicinal product (IMP) treatment on John Young Ward at the National Hospital for Neurology and Neurosurgery.

UCLH has recruited the first participant in the UK for a study testing a new anti-cancer treatment combination for advanced solid tumours such as endometrial and ovarian cancers.

A team of clinicians and researchers at UCLH and UCL have been awarded a £2.8 million grant to combat health inequalities in patients having major surgery.